Yettinahole project a blunder; it can't quench the thirst of parched districts'

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Newsroom, May 22: Countless netizens including Indians have hailed the action taken by Jazan University of Kingdom of Saudi Arabia against a high-ranking Indian expatriate who had posted called Indian Muslims as radicals.  

Social media platforms such as Twitter and Facebook flooded with appreciation after the University announced on Twitter that the professor, who had posted objectionable messsages, had been fired. The university, however, did not disclose the name of the professor. 

On its Twitter account, Jazan University wrote, “Based on what was monitored by the university about the publication of a contracted faculty member for offensive posts and tweets, his registration has already been folded. #JazanUniversity affirms that it resolutely addresses any perverted or extremist ideas that affect the constants or violate the directions of good leadership.”

After the university’s announcement, many on Twitter posted screenshots of the communal tweets claiming that the professor is Neeraj Bedi and made it clear that the dismissed professor is an Indian.

Bedi has been working as full time Professor in Faculty of Public Health and Tropical Medicine in Jazan University for years.

In his Twitter account, which does not currently exist, he was praising PM Modi and spewing poison against Islam and holding Muslims responsible for the spread of Coronavirus. It is believed that the account was deleted after the protests became severe.

Bengaluru, Jul 2: Karnataka government has issued a show-cause notice to 18 private hospitals for refusing to admit a 52-year-old patient with influenza-like illness (ILI) symptoms, who later died.

According to the notice dated on June 30, a 52-years patient named Bhawarlal Sujani died after he was denied admission by 18 private hospitals.

The patient was taken to these hospitals on Saturday and Sunday for admission on observing some ILI like symptoms. But none of these hospitals admitted in on the pretext of unavailability of bed/ventilators, read the notice.

This is a clear violation of providing medical assistance and admission necessitated under the agreed provision of KPME Registration. They should strictly adhere to the provisions under Sections 11 & 11 A of KPME Act 2017. Private Medical Establishments cannot deny/ refuse/ avoid treatment to patients with Covid-19 and Covid-19 like symptoms, the state Health Department said.

By denying the admission to the deceased patient, your hospitals have violated the provisions of the above-said act. You are liable for legal action in this regard, as per the notice.

The state Health department asked the hospitals to reply as to why action should not be initiated under the relevant Acts.